Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio De Benedetti

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Current Opinion in Rheumatology|July 14, 2009
Targeting interleukin-6 in pediatric rheumatic diseasesFabrizio De Benedetti
Advances in Experimental Medicine and Biology|August 8, 2024
Anti-Interferon-γ Therapy for Cytokine Storm SyndromesEdward M Behrens, Fabrizio de Benedetti
Pediatric Rheumatology Online Journal|January 5, 2024
The 4<sup>th</sup> NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?Scott W Canna, Fabrizio De Benedetti
The Journal of Rheumatology|April 17, 2013
Reaching the threshold: a multilayer pathogenesis of macrophage activation syndromeRaffaele Strippoli, Ivan Caiello, Fabrizio De Benedetti
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapiesManuela Pardeo, Claudia Bracaglia, Fabrizio De Benedetti
Current Opinion in Rheumatology|June 14, 2019
Interleukin-18 in pediatric rheumatic diseasesGiusi Prencipe, Claudia Bracaglia, Fabrizio De Benedetti
Pediatric Rheumatology Online Journal|January 19, 2017
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndromeClaudia Bracaglia, Giusi Prencipe, Fabrizio De Benedetti
Nature Reviews. Rheumatology|March 25, 2016
Macrophage activation syndrome in the era of biologic therapyAlexei A Grom, AnnaCarin Horne, Fabrizio De Benedetti
International Journal of Molecular Sciences|May 12, 2017
NGF and Its Receptors in the Regulation of Inflammatory ResponseGaetana Minnone, Fabrizio De Benedetti, Luisa Bracci-Laudiero
Pediatric Rheumatology Online Journal|January 3, 2024
The 4<sup>th</sup> NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design studyFabrizio de Benedetti, Alexei A Grom, Hermine Brunner
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Current Opinion in Rheumatology|July 14, 2009
Targeting interleukin-6 in pediatric rheumatic diseasesFabrizio De Benedetti
Advances in Experimental Medicine and Biology|August 8, 2024
Anti-Interferon-γ Therapy for Cytokine Storm SyndromesEdward M Behrens, Fabrizio de Benedetti
Pediatric Rheumatology Online Journal|January 5, 2024
The 4<sup>th</sup> NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?Scott W Canna, Fabrizio De Benedetti
The Journal of Rheumatology|April 17, 2013
Reaching the threshold: a multilayer pathogenesis of macrophage activation syndromeRaffaele Strippoli, Ivan Caiello, Fabrizio De Benedetti
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapiesManuela Pardeo, Claudia Bracaglia, Fabrizio De Benedetti
Current Opinion in Rheumatology|June 14, 2019
Interleukin-18 in pediatric rheumatic diseasesGiusi Prencipe, Claudia Bracaglia, Fabrizio De Benedetti
Pediatric Rheumatology Online Journal|January 19, 2017
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndromeClaudia Bracaglia, Giusi Prencipe, Fabrizio De Benedetti
Nature Reviews. Rheumatology|March 25, 2016
Macrophage activation syndrome in the era of biologic therapyAlexei A Grom, AnnaCarin Horne, Fabrizio De Benedetti
International Journal of Molecular Sciences|May 12, 2017
NGF and Its Receptors in the Regulation of Inflammatory ResponseGaetana Minnone, Fabrizio De Benedetti, Luisa Bracci-Laudiero
Pediatric Rheumatology Online Journal|January 3, 2024
The 4<sup>th</sup> NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design studyFabrizio de Benedetti, Alexei A Grom, Hermine Brunner
Pageof 20